Globus Medical Inc (GMED) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Globus Medical Inc   (NYSE: GMED)


Globus Medical Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Globus Medical Inc 's ROA in the third quarter of 2026?
Globus Medical Inc achieved a return on average assets (ROA) of 9.82 % in its third quarter of 2026, which is below Globus Medical Inc 's average return on assets, which stands at 10.29%.

However, within the Healthcare sector 94 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 545, from total ROA ranking in the second quarter of 2026 at 640.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 17.72 % 18.83 % 15.46 % 5.18 % 2.07 %
Y / Y Net Income Change 18.66 % -25.28 % 64.72 % 430.44 % 129.5 %
Net Income (TTM) in million 558 535 587 538 424
Return On Assets (TTM) 9.82 % 9.82 % 11.24 % 10.68 % 8.53 %
GMED's Total Ranking # 545 # 640 # 727 # 887 # 1431
Total Assets (TTM) in million 5,998 5,895 5,440 5,375 5,096
Seq. Total Assets Change 1.75 % 8.38 % 1.21 % 5.47 % 2.71 %
Seq. Net Income Change -6.86 % 21.94 % -11.59 % 18.18 % -41.35 %

GMED's 5 Years Annual ROA >> Back to GMED Management Effectiveness >> Compare GMED ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 27
Sector # 95
Overall # 601

Return On Assets Statistics
High Average Low
18.93 %
10.29 %
0.8 %
(Dec 31 2012)   (Jun 30 2024)



  News about Globus Medical Inc Return on Assets ROA

A New Epoch in Medical Innovation Globus Medical Inc. Unveils the ADIRA XLIF Plate System Amidst Financial Variances,...

Globus Medical Heralds New Dawn with ADIRA XLIF Plate SystemIn an age where the boundaries of scientific and medical ingenuity seem ever-expansive, it is with great anticipation and fanfare that we herald the advent of Globus Medical Inc. s latest innovation the ADIRA XLIF Plate System. The esteemed establishment, a paragon in the realm of musculoskeletal solutions, announced their commercial launch on the 21st of August in the year of Our Lord, 2024. This unveiling marks a significant milestone, being the Company s inaugural product launch that aligns seamlessly with its broadened lateral interbody portfolio.Situated in the bucolic yet industrious precincts of Audubon, Pennsylvania, Globus Medical Inc. (NYSE: GMED) has long stood as a bastion of pioneering health solutions. However, the financial nuances of their recent quarterly performances paint a portrait that mingles triumphs with trials.



Financial Statements
Globus Medical Inc 's Assets $ 5,998 million GMED's Balance sheet
Globus Medical Inc 's Income $ 141 million Quarterly GMED's Income Statement
GMED's Income by Division See GMED's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 5.18 % 1.79 % 141.46 % 6.22 % 16.54 %
Total Assets in million 5,375 5,110 5,020 2,079 1,957
Y / Y Net Income Change 422.28 % -16.19 % -35.39 % 27.47 % 45.86 %
Net Income in million 538 103 123 190 149
Annual Return On Assets 10.01 % 2.02 % 2.45 % 9.15 % 7.62 %

GMED's 5 Years Annual ROA >> Back to GMED Management Effectiveness >> Compare GMED ROA to its Competitors



Comment on GMED's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 10.01 % compared to prior year, due to annual net income growth of 422.28 % to $537.87 million, while value of Globus Medical Inc 's overall assets grew just by 5.18 % to $5,374.58 million, compared to $5,374.58 a year before.


More Return On Assets Ratios
GMED's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GMED's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GMED's Competitors
Subscribers only: Roa for Globus Medical Inc 's Suppliers
Subscribers only: Return On Assets for GMED's Customers

You may also want to know
GMED's Roi GMED's Inventory Turnover Ratio GMED's Growth Rates GMED's Dividend Comparisons
GMED's Profitability Ratios GMED's Asset Turnover Ratio GMED's Dividend Growth
GMED's Roe GMED's Valuation Ratios GMED's Financial Strength Ratios GMED's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Zevra Therapeutics Inc   26.33 %
Caredx Inc   25.74 %
Medpace Holdings Inc   24.47 %
Acadia Pharmaceuticals Inc   21.60 %
Standard Biotools Inc   21.56 %
Eli Lilly And Company  21.24 %
Iradimed Corporation  20.89 %
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %

Date modified: 2026-11-06T12:56:24+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.